Abstract
Aim:
To investigate the anticancer effects and the molecular mechanisms of deguelin on human U937 leukemia cells, and to explore the underlying mechanism regulating nucleoporin 98 (Nup98) and nucleoporin 88 (Nup88) in vitro.
Methods:
The effects of deguelin on the growth of U937 cells were studied by MTT assay. The effect of deguelin on the cell cycle of U937 cells was studied by using a propidium iodide method. The localization of the nuclear pore complex proteins Nup98 and Nup88 was investigated by using immunofluorescence and immunoelectron microscopy. The expression of Nup98 and Nup88 in U937 cells was investigated by using flow cytometry and Western blot.
Results:
The proliferation of U937 cells was inhibited in the deguelin-treated group, with a 24-h IC50 value of 21.61 nmol/L and a 36-h IC50 value of 17.07 nmol/L. U937 cells treated with deguelin had reduced percentages of cells in the G0/G1 phase, whereas cells accumulated in the S and G2/M phases. Nup88 and Nup98 were found on both the nuclear and cytoplasmic sides of the U937 cells by using immunofluorescence and immunoelectron microscopy. The expression of Nup98 was upregulated and that of the Nup88 protein was downregulated in U937 cells treated with deguelin.
Conclusion:
Deguelin is able to inhibit the proliferation of U937 cells by regulating the cell cycle such that cells are arrested at the S and G2/M phases, so that the proportion of cells in the G0/G1 phase decreases. The antitumor effects of deguelin are related to upregulating the expression of Nup98 and downregulating the expression of Nup88 protein in U937 cells.
Similar content being viewed by others
Article PDF
References
Frosst P, Guan T, Subauste C, Hahn K, Gerace L . Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol 2002; 156: 617–30.
Enninga J, Levy DE, Blobel G, Fontoura BM . Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 2002; 295: 1523–5.
Griffis ER, Xu SL, Powers MA . Nup98 localizes to both nuclear and cytoplasmic sides of the nuclear pore and binds to two distinct nucleoporin subcomplexes. Mol Biol Cell 2003; 14: 600–10.
Griffis ER, Altan N, Lippincott-Schwartz J, Powers MA . Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Mol Biol Cell 2002; 13: 1282–97.
Nerea M, Angel A, Moragues MD, Jose P, Jose S . The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res 1999; 59: 5408–11.
Udeani GO, Gerhauser C, Thomas CF, Moon RC, Kosmeder JW, Kinghorn AD, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res 1997; 57: 3424–8.
Lee HY, Suh YA, Kosmeder JW, Pezzuto JM, Hong WK, Kurie JM . Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells. Clin Cancer Res 2004; 10: 1074–9.
Chun KH, Kosmeder JW 2nd, Sun S, Pezzuto JM, Lotan R, Hong WK, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 2003; 95: 291–302.
Murillo G, Salti GI, Kosmeder JW, Pezzuto JM, Mehta RG . Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer 2002; 38: 2446–54.
Bortul R, Tazzari PL, Billi AM, Tabellini G, Mantovanil L, Cappellini A, et al. Deguelin, a PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. Br J Haematol 2005; 129: 677–86.
Liu HL, Chen Y, Cui GH, Wu QL, He J . Experimental study on regulating expressions of cyclin D1, pRb, and anticancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro. Acta Pharmacol Sin 2005; 26: 873–80.
Liu HL, Chen Y, Cui GH, Zhou JF . Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation effect. Acta Pharmacol Sin 2005; 26: 603–9.
Evan GI, Vousden KH . Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–8.
Sun SY, Hail N Jr, Lotan R . Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004; 96: 662–72.
Pietenpol JA, Stewart ZA . Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002; 181: 475–81.
Hodel AE, Hodel MR, Griffis ER, Hennig KA, Ratner GA, Xu S, et al. The three-dimensional structure of the autoproteolytic, nuclear pore-targeting domain of the human nucleoporin Nup98. Mol Cell 2002; 10: 347–58.
Gould VE, Martinez N, Orucevic A, Schneider J, Alonso A . A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development. Am J Pathola 2000; 157: 1605–13.
Kobzev YN, Martinez-Climent J, Lee S, Chen J, Rowley JD . Analysis of translocations that involve the NUP98 gene in patients with 11p 15 chromosomal rearrangements. Genes Chromosomes Cancer 2004; 41: 339–52.
Slape C, Aplan PD . The role of NUP9 8 gene fusions in hematologic malignancy. Leuk Lymphoma 2004; 45: 1341–50.
Zhang H, Schneider J, Rosdahl I . Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol 2002; 21: 43–8.
Agudo D, Gomez EF, Martinez AF, Nunez MJ, Pollan M, Schneider J . Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 2004; 109: 717–20.
Gould VE, Orucevic A, Zentgraf H, Gattuso P, Martinez N, Alonso A . Nup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 2002; 33: 536–44.
Boer J, Bonten-Surtel J, Grosveld G . Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocyto-plasmic transport defects, and apoptosis. Mol Cell Biol 1998; 18: 1236–47.
Author information
Authors and Affiliations
Additional information
Project supported by the National Natural Science Foundation of China (No 30472267).
Rights and permissions
About this article
Cite this article
Liu, Hl., Chen, Y., Cui, Gh. et al. Deguelin regulates nuclear pore complex proteins Nup98 and Nup88 in U937 cells in vitro. Acta Pharmacol Sin 26, 1265–1273 (2005). https://doi.org/10.1111/j.1745-7254.2005.00192.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00192.x
Keywords
This article is cited by
-
Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation
Annals of Hematology (2015)
-
Regulatory effects of deguelin on proliferation and cell cycle of Raji cells
Journal of Huazhong University of Science and Technology [Medical Sciences] (2013)
-
Effects of gambogic acid on the regulation of nucleoporin Nup88 in U937 cells
Journal of Huazhong University of Science and Technology (2007)